Post-COVID Cognitive Fog: What We Know and How to Track Recovery

The Fog That Stayed

The fever broke. The cough cleared. You tested negative, went back to work, and assumed the worst was over. But something didn't come back. Your thinking felt slower — not dramatically, not enough to alarm anyone, but enough that you noticed. Conversations required more effort. Multi-step tasks felt harder. Mental arithmetic that used to be automatic now demanded concentration. The word you hear most often from people in this situation is "fog" — and the word is apt, because like fog, it's diffuse, hard to pin down, and impossible to see through.

Post-COVID cognitive fog — sometimes called "brain fog" or part of the broader long COVID syndrome — affects a significant portion of people who've had COVID-19. An estimated 7% of U.S. adults reported having long COVID symptoms as of early 2024, according to CDC data. Among those, close to half report cognitive difficulties including poor memory and brain fog, according to Yale Medicine researchers.

What the Research Shows

The cognitive effects of long COVID are real, measurable, and increasingly well-characterized. A longitudinal study from Mount Sinai Health System, published in 2025 and tracking patients for up to 42 months after acute infection, found that while cognition improved progressively over time across most domains — attention, working memory, verbal learning — two specific domains remained impaired: processing speed and executive functioning. Both remained more than one standard deviation below the normative mean even at 42 months post-infection.

These are precisely the cognitive systems that mental arithmetic demands most heavily. Processing speed determines how fast you retrieve math facts. Executive functioning governs your ability to hold a plan, inhibit distractions, and manage multi-step procedures. When both are impaired, the subjective experience is exactly what patients describe: "I know I can do this, but it takes so much more effort than it used to."

A 2025 study published in Brain Communications by researchers at Yokohama City University identified a biological mechanism: widespread increases in AMPA receptor density in the brains of long COVID patients, linked to both cognitive impairment and neuroinflammation. This finding confirmed that brain fog is a measurable, biological condition — not a psychological symptom or a matter of motivation.

Post-COVID brain fog isn't "just tiredness." Processing speed and executive function can remain measurably impaired for years after infection. Tracking recovery requires a metric that runs more often than a yearly doctor's visit.

Why Standard Assessments Miss the Trajectory

Clinical cognitive assessments — the Montreal Cognitive Assessment, neuropsychological test batteries — are valuable for diagnosis. But they're snapshots. They tell you where you are on the day you take the test, not how you've been trending over the past three months. For a condition like long COVID brain fog, where improvement is gradual and non-linear, the trajectory matters as much as the current score.

A daily Sharpness Score fills this gap. Sixty seconds of timed mental arithmetic each morning generates a data point that captures your processing speed and working memory function against your own rolling baseline. Over weeks and months, the trend line tells a recovery story that a single clinical assessment can't. Is your processing speed improving? Is the improvement steady or fluctuating? Are there triggers — stress, poor sleep, overexertion — that cause temporary setbacks?

This kind of longitudinal self-tracking is especially relevant for long COVID because the RECOVER-NEURO clinical trial, whose results were published in JAMA Neurology in 2025, found that participants in all treatment arms — including the control group — showed modest cognitive improvements over time. This means tracking recovery requires distinguishing between natural improvement and treatment-specific effects, which is only possible with frequent, consistent measurement.

What Daily Tracking Can and Cannot Do

A daily cognitive metric is not a treatment for long COVID brain fog. It does not replace medical evaluation, neuropsychological testing, or the pharmacological and rehabilitative interventions being developed for this condition. What it provides is something those tools cannot: daily resolution. A time series that makes the invisible visible.

For someone recovering from post-COVID cognitive fog, the practical value is threefold. First, it provides objective evidence of improvement that subjective experience often misses — you might feel foggy on a day when your actual processing speed is 5% above last month's average. Second, it identifies patterns: which days are worse, which behaviors correlate with setbacks, and whether recovery is actually happening or has plateaued. Third, it gives you data to bring to your doctor — not "I feel like I'm getting better" but "my arithmetic processing speed has improved 12% over the past eight weeks, with a consistent upward trend."

Who Benefits Most from Daily Tracking

Not everyone with post-COVID cognitive symptoms needs a daily cognitive metric. If your brain fog resolved within weeks of your acute infection — as it does for the majority of people — you're already past the point where daily tracking adds value. The people for whom this tool is most useful are those experiencing persistent symptoms: the subset whose cognitive difficulties last months or years, who are navigating medical appointments and rehabilitation programs, and who need a way to quantify what's happening between those appointments.

Healthcare providers managing long COVID patients have also expressed interest in daily patient-generated cognitive data as a supplement to in-clinic assessments. A daily Sharpness Score time series — showing clear trends across weeks and months — gives a clinician more actionable information than a single-point-in-time assessment conducted in an unfamiliar clinical environment (which itself may not represent the patient's typical cognitive state due to stress and unfamiliarity).

A Note on Expectations

If you're experiencing post-COVID cognitive fog, the Mount Sinai longitudinal data offers both honest concern and genuine hope. Processing speed and executive function can remain below pre-COVID levels for an extended period — this is real and shouldn't be minimized. But the data also shows consistent improvement across most cognitive domains over time. The trajectory is upward, even if the pace is slower than you'd like.

A daily Sharpness Score won't accelerate that trajectory. But it will make it visible. And for a condition defined by invisible symptoms that others can't see and you can barely articulate, visibility is not a small thing. The fog is real. The recovery is real too. Tracking it daily gives you evidence for both — and evidence is what turns a vague feeling of "something is wrong" into a concrete understanding of where you've been and where you're heading.